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Abstract Limited proteolysis of protein kinase C (PKC) by 
calpain under cell free conditions cleaves the regulatory and cat- 
alytic PKC subunits, generating a free, co-factor independent 
catalytic snbunit, termed PKM. In the present study, we de- 
monstrate distinct differences in the rate, nature, and lipid-sensi- 
tivity of PKC and PKM proteolysis by pM and mM calcium- 
requiring calpain isozymes (p calpain or m calpain, respectively). 
PKC is a preferred substrate for m calpain; not even a 100-fold 
increase in/.t calpain was capable of degrading PKC as fast as 
in calpain. PKM was generated by both m and/t calpains, but 
was itself rapidly degraded by m calpain and therefore was only 
transiently detectable. By contrast, PKM was formed but not 
degraded by p calpain, and persisted in the presence of p calpain 
long after all PKC had been degraded. Phosphatidyl serine (PS) 
inhibited PKC hydrolysis by m calpain yet enhanced PKC hydrol- 
ysis by /z calpain. The ability of either calpain isoenzyme to 
degrade [~4C[azocasein was unaffected by PS, suggesting that the 
influence of PS was on PKC conformation. These findings point 
towards distinct roles for p and m calpain in PKC regulation. 
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ated process by the protease inhibitor leupeptin underscores the 
potential physiological importance of limited PKC proteolysis 
[13]. Moreover, some interrelationship may exist between these 
two modes, since phospholipid-mediated activation of PKC 
apparently facilitates its hydrolysis by calpain [8,9]. 
In the present study, we examine PKC proteolysis by/1 and 
m calpain, and the influence of phospholipids on this proces. 
Portions of this research ave been presented in abstract form 
[14]. 
2. Materials and methods 
2.1. Partial purification of g and m calpain 
m calpain was purified from post-mortem human brain by sequential 
chromatography on DE-52 cellulose, phenyl sepharose and Ultrogel- 
AcA-44 as previously described [15]. /1 calpain was purified from 
human erythrocytes by sequential chromatography on DE-52 cellulose 
followed by phenyl sepharose CL-4B [12].//calpain was also purified 
from bovine brain gray matter by identical methodology [12], followed 
by immunoprecipitation of residual m calpain with a polyclonal anti- 
body (C7) directed against m calpain. Calpain activity was assayed 
against ~4C-labeled azocasien as described [15]. One unit (U) of specific 
activity was defined as that amount of purified m and/t calpain required 
to degrade 1 ¢tg azocasien/min at 30°C; 1 U corresponded to 1.2/,tg of 
m calpain and 2.1 ¢tg of/~ calpain in these analyses. 
I. Introduction 
Protein kinase C is a family of Ser/Thr kinases that regulate 
intracellular signal transduction mechanisms [1]. PKC consists 
of a catalytic domain and regulatory domain, the latter of which 
requires activating cofactors including Ca >, phospholipid, and 
diacylglycerol (DAG), which induce a conformational change 
that permits substrate interaction [2]. Limited proteolysis of 
PKC by calcium-activated proteases cleaves the catalytic and 
regulatory subunits, generating a cofactor-independent, free 
catalytic subunit, termed PKM [3 5]. Unlike membrane- 
bound, intact PKC, PKM has potential access to a distinct set 
of non-membrane-associated protein substrates [6]. The re- 
sponsible calcium-activated proteases, calpains, exist as distinct 
isoforms that are activated in cell-free analyses at micromolar 
or millimolar Ca 2+ concentrations (termed '/~ calpain' and 
'm calpain', respectively); their respective Ca z+ requirements in 
situ are unknown [7-12]. 
The respective roles of these two modes of PKC activation 
remain unclear; however, the inhibition of certain PKC-medi- 
*Corresponding author. Fax: (1) (508) 934 3062. 
2.2. Incubation of purified PKC with mM calpain 
PKC ~ from rabbit brain (1 ¢tg; UBI, Inc., Lake Placid, NY) was 
incubated with 1 100 activity units of either calpain for 0-60 min at 
30°C in 50 mM Tris-HCl (pH 7.4) containing 2 mM PMSF and 2 mM 
CaC12, after which the reaction was stopped by the addition of 2 x SDS 
treatment buffer on ice. Additional PKC samples were incubated for 
60 min in the absence of calpain, under which no degradation was 
observed (not shown; see [5]). In some experiments, 0.5 mg/ml 
phosphatidylserine (PS; Serdary Research Laboratory, Ontario, Can- 
ada) was included. 
2.3. Gel electrophoresis and immunoblot analysis 
Samples were electrophoresed on SDS 7% polyacrylamide g ls and 
transferred tonitrocellulose. The co-migration ofcalpain (76-80 kDa) 
and PKC (80 kDa) necessitated the use of immunoblot methodologies 
to monitor proteolytic degradation of PKC. Nitrocellulose replicas 
were probed with a 1 : 300 dilution of a commercial monoclonal nti- 
body that specifically recognizes the catalytic domain of PKC c~ (UBI), 
followed by reaction with alkaline phosphatase-conjugated goat anti- 
mouse antibody and visualization as described [16]. 
2.4. Densitometric analysis of nitrocellulose r plicas 
Nitrocellulose replicas were scanned at optimal contrast within a 
linear ange using a Hewlett-Packard Scan Jet IIp scanner connected to
a Macintosh MacPlus computer. The resulting digitized immunoblot 
profiles were analyzed with Scan Analysis oftware (BioSoft, Ferguson, 
MO) and values were exported into Excel and Cricket Graph software 
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Fig. 1. Proteolysis ofPKC by/z and m calpain. PKC (l/tg) was incubated with 0.035 U ofm calpain or 4,21 U ofg calpain in the presence of CaC12 
at 30°C for 0-60 min without and with 0.5 mg/rnl phosphatidyl serine (PS) as indicated. Note that PKC immunoreactivity was eliminated substantially 
more rapidly in the presence of m calpain than g calpain. Note also that PKM was detected only transiently during incubation with m calpain, yet 
persisted following its generation by g calpain. Note that PS decreased the rate of PKC degradation by m calpain but increased PKC and PKM 
degradation by ~ calpain. 
m calpain g calpain 
lOOq 
50- ~ 1 
_ 
0 n J m m u 
100 
" r  
50 
25 
o l  - ~ I 
0 20 40 60 0 2'0 4'0 60 
-PS 
+PS 
Time of lncubation (min) 
Fig. 2. Quantitation of PKCcc degradation profiles by/z and m calpain. Nitrocellulose r plicas of PKC degradation profiles by calpain in the presence 
and absence of PS were digitized and quantitated as described in section 2. Values are presented as the mean + standard error of the mean obtained 
from 3 separate xperiments. 
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Fig. 3. Degradation rates of PKC. Regression analyses of linear portions of PKC degradation profiles were calculated as described in section 2. PS 
decreased PKC degradation by m calpain by 47%, and enhanced PKC degradation by p calpain by 45%. 
as described [17]. Staining intensity obtained for PKC at 0 incubation 
time for each nitrocellulose r plica was defined as 100%, and all addi- 
tional immunoreactive PKC and PKM bands on each respective r plica 
were calculated as percentages relative to their respective PKC value 
at time 0. 
Representative nitrocellulose replicas are illustrated, and corre- 
sponding raphs represent the mean + the standard error of the mean 
derived from analysis of replicas from 3 separate experiments. It should 
be noted that the relative affinity of this monoclonal antibody for the 
native enzyme (PKC) versus the proteolytically-cleaved catalytic do- 
main (PKM) is unknown and therefore cannot be compared. Calcula- 
tion of PKM as a percentage ofPKC at time 0 serves only as a reference 
point for construction of graphs, since in many instances there is no 
detectable PKM at time 0. In this study, no attempt ismade to compare 
the absolute amount of PKM irnmunoreactivity with that of PKC; the 
relative presence of PKM or PKC are separately evaluated by their 
respective immunoreactivities during incubation with calpain. PKC 
degradation rates were calculated by plotting the mean + standard 
error of the initial decay rates (0-1 min), and best-fit lines were gener- 
ated by Cricket Graph software. The percentage change in rate of PKC 
degradation i the presence of PS was determined by the formula (mean 
degradation rate with PS/mean degradation rate without PS)× 100. 
3. Results 
PKCa was degraded following incubation with either/t  or 
m calpain in the presence of CaC12 (Fig. 1). This loss of PKC 
was accompanied by the appearance of PKM immunoreactivity 
at 46 kDa. PKC was a preferred substrate for m calpain as 
compared to/~ calpain. While incubation of PKC with 0.035 U 
of m calpain rapidly depleted PKC immunoreactivity (Fig. 1), 
the identical activity U of / l  calpain did not degrade PKC (not 
shown); moreover, even a 100-fold excess in/a calpain activity 
U did not degrade PKC as fast as m calpain (Figs. 1 and 2). 
Consistent with previous tudies [5], PKM was only weakly and 
transiently detected uring PKC hydrolysis by m calpain. By 
contrast, PKM was generated by p calpain but apparently did 
not undergo further degradation (Figs. 1 and 2). That the 46 
kDa PKC-immunoreactive polypeptide generated in these reac- 
tions was, in fact PKM, was previously confirmed by its ability 
to phosphorylate a peptide corresponding to amino acid resi- 
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Fig. 4. Effect of PS on/t and m calpain activity. The degradation of 100 pg [J4C]azocasien by 2.5/.tg or 1.0/.tg of m and/z calpain, respectively, was 
performed as described [13] without and with 0.5 mg/ml PS, Values presented represent the mean + standard error of the mean for 3 separate 
experiments. Note that the rate of azocasein degradation by either calpain was not affected by these phospholipids. 
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Fig. 5. Relative resistance of PKM to/1 calpain-mediated proteolysis. 
PKC (1/lg) was incubated from 0-60 rain with 4.21 U of/~ calpain, 0.5 
mg/ml PS and 2 mM CaCI2 at 30°C. After 14 min, some samples 
received an additional 4.21 U of/l calpain or an additional 1 ,ug of PKC 
as indicated and reactions were continued. Note the persistence of 
PKM following introduction of additional # calpain, and the rapid 
proteolysis of additional PKC. 
dues 4-14 of myelin basic protein in the absence of PKC- 
specific ofactors [5]. 
We next examined the impact of PS on calpain-mediated 
PKC hydrolysis, which activates PKC by inducing a conforma- 
tional change in the regulatory subunit [2]. PS slowed m cal- 
pain-mediated PKC degradation by approximately 47% yet 
increased the rate of PKC degradation by ¢t calpain by approx- 
imately 45% (Figs. 1 3). PKM underwent degradation by 
/~ calpain in the presence of PS (Figs. 1 and 2). Degradation of 
[~4C]azocasein by either calpain was unaffected by PS (Fig. 4), 
suggesting that the influence of PS on PKC degradation was 
not due to a direct effect of PS on either calpain. 
This possibility remained that the accumulation ofPKM was 
a reflection of rapid depletion of/~ calpain activity during the 
first few minutes of PKC degradation. However, introduction 
of additional/~ calpain at 14 min (by which time all PKC had 
been hydrolyzed) resulted in an insignificant loss of PKM (Fig. 
5). Moreover, additional PKC introduced into the reaction 
after 14 rain was rapidly degraded, resulting in further PKM 
accumulation (Fig. 5). These findings confirm that PKM accu- 
mulation was not a result of rapid depletion of/~ calpain activity 
during the initial phases of PKC hydrolysis in our assay sys- 
tems, and confirm that the accumulation of PKM is indeed a 
reflection of it being a poorer/~ calpain substrate than is intact 
PKC. The possibility that the relative inability to degrade PKM 
represented a unique characteristic of erythrocyte ¢z calpain was 
eliminated by the observation of identical patterns of PKC 
hydrolysis and PKM accumulation following incubation with 
/~ calpain from bovine brain (Fig. 6). 
4. Discussion 
In the present study we observed ifferential rates of proteol- 
ysis of PKC and the resultant free catalytic subunit PKM by 
/1 and m calpain. PKC underwent rapid proteolysis by m cal- 
pain in the absence of lipids forming transiently detectable 
PKM, but in the presence of lipids, m calpain-mediated prote- 
olysis of PKC is inhibited. By contrast,/1 calpain hydrolyzed 
PKC faster in the presence of lipids than without lipids produc- 
ing PKC both cases. Once formed, PKM was not further de- 
graded by/~ calpain under these conditions. 
The results indicate that PKM is a good substrate for m 
calpain (see also [5]), but a poor substrate for/~ calpain. One 
possible implication of these findings is that limited PKC prote- 
olysis by / l  calpain may be part of a mechanism to induce 
relatively localized PKM-specific phosphorylation, e.g. of 
transmembrane membrane proteins such as MARKCS and 
other integins, and several membrane-skeletal proteins [1,19]. 
Although PKM is thought o be formed at the plasma mem- 
brane, it is free to migrate into the cytosol it is liberated from 
the lipid-binding region within the regulatory domain of PKC 
[13]. PKM formed as a result of/1 calpain activity may be 
eliminated by m calpain following its diffusion away from the 
inner membrane. This possibility is consistent both with the 
preferential localization of/~, but not m, calpain at the plasma 
membrane and with our data showing a preference of/l calpain 
for the active form of PKC and m calpain for the native confor- 
mation. In this regard, PKM, although co-factor independent 
and not restricted to the membrane, should not be considered 
to be 'unregulated' kinase; in fact, our data showing that PKM 
is degraded faster than PKC demonstrate hat PKM is actually 
under tight regulation by m calpain-mediated proteolysis [5]. 
Another possible implication of the present findings is that 
disregulation of calpains accompanying certain pathophysiol- 
ogical conditions may rise to the persistently high levels of 
PKM [19,20]. Calcium influx at a concentration sugfficient to 
induce hyperactivation f/1, but not m calpain could rapidly 
generate PKM, which II calpain may not degrade further, or 
may do so only relatively slowly. Consequently, excessive 
amounts of PKM may enter the cytosolic compartment and 
initiate phosphorylation f inappropriate substrates, and/or hy- 
perphosphorylation of otherwise normal substrates. The poten- 
tial role of abnormally high levels of PKM activity in the patho- 
genesis of certain conditions remains an important area of 
investigation. 
While numerous tudies in cell-free systems have demon- 
strated that limited proteolysis of PKC generates a co-factor 
independent, free catalytic subunit ('PKM'), the difficulty in 
demonstrating the presence of PKM in intact cells has gener- 
ated controversy concerning the physiological relevance of this 
process [13]. Whether or not PKM indeed exists within intact 
cells is of considerable importance in understanding the full 
nature and extent of the roles of PKC in situ, because PKM can 
theoretically act on additional classes of substrates that are 
inaccessible to its membrane-associated, cofactor-dependent 
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Fig. 6. Comparison of PKC degradation and PKM accumulation by 
/1 calpain from human erythrocytes and bovine brain. PKC ct was 
incubated for 0 min or 60 min in the presence of CaC12, 4.21 U of 
erythrocyte/1 calpain ('red blood cells'), 4.21 U ('bovine brain', first 
lane incubated for 60 min) or 8.42 U ('bovine brain', second lane 
incubated for 60 min) bovine brain,u calpain. Note PKC hydrolysis and 
PKM accumulation with ¢t calpain from both sources. 
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parent enzyme [11]. The findings of the present study provide 
insight into the nature of limited proteolysis of PKC by calpain, 
and point towards potentially different physiological roles for 
/t and m calpain in the regulation of this enzyme. Moreover, 
these findings present the first documentation for potential 
functional differences between the calpain isozymes. These 
data, however, do not confirm the physiological significance of 
PKM, which would require the demosntration f PKM-specific 
substrate phosphorylation in situ. In addition, these studies do 
not address whether or not additional proteases are active 
against PKC and/or PKM, and whether or not alternative 
methods of PKC activation, or alternative cleavage patterns 
can result in PKC down-regulation without generating PKM. 
Indeed, PKM was not visualized in SH-SY-5Y cells during 
TPA-mediated PKC activation and ultimate down-regulation, 
nor following TPA treatment of neutrophils [21]. While studies 
have implicated proteolysis of PKC as a necessary component 
of TPA-mediated PKC down-regulation [5,7,10,22], it remains 
to be determined whether or not significant levels of PKM are 
transiently generated uring this process. Although the results 
of the present study confirm that both calpain isoforms readily 
degrade PKC in cell-free studies, it is yet unclear whether or not 
/~ calpain, in calpain or both are responsible for in situ proteol- 
ysis of PKC. Finally, in the present study, we have examined 
the calpain-mediated degradation of the alpha isoform of PKC 
and results presented herein are therefore potentially unique for 
that isoform. Since evidence is accumulating that the various 
PKC isozymes display unique neuronal localizations and sensi- 
tivities and mediate distinct functions, it should be considered 
that the other isoforms [8], and any respective PKM derived 
from them, may display distinct degradation profiles [23,24]. 
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